Masked polycythemia vera diagnosed according to WHO and BCSH classification. - Wikidata - wikimedia - TriplyDB

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

http://www.wikidata.org/entity/Q54400423

about

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis Management of polycythaemia vera: a critical review of current data.Current and future treatment options for polycythemia vera.Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria Novel insights into the biology and treatment of chronic myeloproliferative neoplasms.From leeches to personalized medicine: evolving concepts in the management of polycythemia vera.Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera.How we diagnose and treat essential thrombocythaemia.Myeloproliferative neoplasms: A decade of discoveries and treatment advances.Myeloproliferative neoplasms: Morphology and clinical practice.European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group.Progression of primary myelofibrosis to polycythemia vera: A case report.Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.From anemia to polycythemia in 4 weeks.Straightforward identification of masked polycythemia vera based on proposed revision of World Health Organization diagnostic criteria for BCR-ABL1-negative myeloproliferative neoplasms.JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.Frequency of polycythemia in individuals with normal complete blood cell counts according to the new 2016 WHO classification of myeloid neoplasms.Comparison of JAK2(V617F) -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.SOHO State-of-the-Art Update and Next Questions: MPN.Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.

P2860

Q26772881-656C830C-1DAD-497B-8704-E1BF6494ACF6 Q31009757-1E24FE59-DE45-400B-9990-88E9674AD743 Q35572748-EA0B35C4-4F02-498C-B16F-159DC41AB685 Q36874807-9A3ABAFD-EAFB-4150-B125-3EC55BB9A104 Q37361527-842DF5B7-5AFC-4061-A754-60F688A138B6 Q37555790-2CBAA88B-9E0C-406E-A93F-AF122DB18ADF Q38420817-CEC3B006-6CD1-4FBC-9AA5-A5E1203BD0B9 Q38606595-99896339-2CA1-4DEB-B4BB-83D9AF705EA7 Q38613880-04940E11-4637-425A-AFE1-8D92FD25FBE9 Q38683559-D4292118-72D0-4E09-A65F-9A54C098C85E Q38689790-4C3CBC75-72BC-436D-A1F7-CBD76B879A3B Q38816384-B70A2D00-8183-420B-A6CE-D223B8376271 Q41049859-AD3F4D86-6146-4305-8662-1F17CAA51D58 Q41085322-8D03B9D2-0C62-4A94-B624-0CFDF127EA6E Q41599861-F3D460FA-9AF7-484D-B7D2-D851BEEBFF52 Q43243282-FFA4C39C-AD12-4F3F-B963-3B3A619B3990 Q45797468-9FB0AAA9-BA0A-4CBA-846D-45C75F8F2E4A Q47829592-8EA6724C-6B06-4EA3-8E04-E4EC0427648C Q48138032-57ABA6D3-AAB2-4BAB-A7BF-E01A5E11B9B7 Q49580473-CFCB252E-DCB7-4B87-966D-56F182108A63 Q50449411-83278A9A-5AE6-402A-A780-B5CA831F7E88 Q54329508-F251F162-D15C-4B0B-923B-1919C2E0D3CE Q54376493-3A0C58C6-FD4F-4937-BC1D-0D1A25D3C2AF

P2860

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

http://www.wikidata.org/entity/Q54400423

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@en

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@nl

type

label

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@en

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@nl

prefLabel

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@en

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@nl

P1433

Q54400423-6A3AD7BE-C877-4C52-9B08-D57595BF26D2

P1476

Q54400423-9B899580-C391-4055-9575-59A73016627A

P2093

Q54400423-2B036960-C35A-4CCC-A048-C9A44A7940F6

Q54400423-42DBFF48-D2FB-463C-AA0F-61FC5E315147

Q54400423-76BFC742-7167-47AC-A3E7-8C9BB5CADDC7

Q54400423-845ECBA8-A4B9-4F80-A1C7-33F4590ABA9C

Q54400423-84944904-36C8-4949-A479-6659300508A6

Q54400423-9FF6C072-2628-4DDC-B696-418B66949961

Q54400423-A54DF59B-D77B-4B8E-856E-FC717BC908BB

Q54400423-B04E7587-9A38-4811-9B4B-0A76FDDFB66A

Q54400423-B1FE6735-3C9B-4186-AE22-1946DD4F1085

Q54400423-CC2B4AB6-8F1C-4AAB-9982-418E0ECF6653

P2860

Q54400423-244ABA8E-BAB7-4DCA-B1C8-F5FCD81E9308

Q54400423-4E87D956-AF83-4262-80C3-14C38A264B80

Q54400423-58B3961A-C995-4C7E-8B0D-CAD38B5EC96F

Q54400423-82A331C9-28D1-4B2E-8AFE-E9957D539303

Q54400423-9B2D1E17-7BD3-4AB0-9FB3-F651DA97E9B6

Q54400423-9D566A85-5A98-43A2-AF43-894EFECDA652

Q54400423-D162AB4D-E372-407B-BB45-CB1B17BC48BC

Q54400423-F5279E28-1FBE-40FC-88CD-493240988F33

Q54400423-FB0F7C0F-24A8-4FC4-AD16-4694A7758761

P304

Q54400423-C6A27508-A945-4A17-B78A-1CDF287131FE

P31

Q54400423-3AC7ECF0-72DB-43F0-A53B-D5EBA1AA82EF

P356

Q54400423-2C4C9779-0E92-44EA-8C30-69D1DB1168A0

P433

Q54400423-BCF97CE9-747A-4A06-A08A-B05935429A70

P478

Q54400423-857378F2-546C-4122-B809-2E92EC693129

P50

Q54400423-A7142333-2335-4D52-8300-F8FF7C9491EB

P577

Q54400423-F8542E2A-390A-4FBD-BC45-94ED521B308F

P698

Q54400423-62687043-2C64-4159-8945-0EA5918629E4

P356

P1433

American Journal of Hematology

P1476

Masked polycythemia vera diagnosed according to WHO and BCSH classification.

@en

P2093

Alessandra Carobbio

http://www.w3.org/2001/XMLSchema#string

Alessandro M Vannucchi

http://www.w3.org/2001/XMLSchema#string

Alessandro Rambaldi

http://www.w3.org/2001/XMLSchema#string

Bettina Gisslinger

http://www.w3.org/2001/XMLSchema#string

Elisa Rumi

http://www.w3.org/2001/XMLSchema#string

Guido Finazzi

http://www.w3.org/2001/XMLSchema#string

Heinz Gisslinger

http://www.w3.org/2001/XMLSchema#string

Jürgen Thiele

http://www.w3.org/2001/XMLSchema#string

Leonhard Müllauer

http://www.w3.org/2001/XMLSchema#string

Marco Ruggeri

http://www.w3.org/2001/XMLSchema#string

P2860

Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia.

The histopathology of chronic myeloproliferative diseases.

The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal.

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.

Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.

The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.

P304

199-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23617

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24166817

http://www.w3.org/2001/XMLSchema#string